ArticleHypertension research : official journal of the Japanese Society of Hypertension2026
Telmisartan, P-glycoprotein inhibition, and bleeding risk in DOAC-treated patients with atrial fibrillation.
Hirofumi Tomita et al.PubMed ↗Publisher ↗
No numbers read from the abstract.